Subsequently, our Western blot analysis confirmed that LC3-II levels increased, while p62/SQSTM1 levels decreased, in a time-dependent manner in both glioma cells upon exposure to RSL3 or erastin (Fig. 3a and Supplementary Fig. 3a). Here, SQSTM1 is linked to central nervous system cancer.